Josh Mailman is an internationally recognized advocate for neuroendocrine tumor patients as well as an advocate for integrative oncology, nuclear medicine, and molecular imaging. He is the inaugural chairman of the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) Patient Advocacy Advisory Board, a member of the Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF) Board, and President of NorCal CarciNET Community. Most recently he was appointed to the Nuclear Regulatory Commission’s Advisory Committee for the use of Nuclear Isotopes and to the American Society of Clinical Oncology’s Scientific Research Committee. Mr. Mailman has an MBA from the Anderson School of Management at UCLA and has been a technology entrepreneur for over 30 years.